Sunshine Biopharma Inc. (SBFM): Total Liabilities
$7.04M
As of 2025-12-31
$6.09M
As of 2026-06-30
-2.6%
3-year compound annual growth
+28.6%
5-year compound annual growth
+18.7%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.04M | -0.3% | 2026-04-03, Balance as of period end |
| 2024-12-31 | $7.06M | +15.0% | 2026-04-03, Balance as of period end |
| 2023-12-31 | $6.14M | -19.4% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $7.62M | +282.5% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $1.99M | -0.5% | 2023-04-04, Balance as of period end |
| 2020-12-31 | $2.00M | +140.0% | 2022-03-21, Balance as of period end |
| 2019-12-31 | $833.5K | -30.7% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $1.20M | +44.7% | 2020-05-01, Balance as of period end |
| 2017-12-31 | $830.8K | +203.1% | 2019-04-12, Balance as of period end |
| 2016-12-31 | $274.1K | -78.4% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $1.27M | +139.2% | 2017-04-17, Balance as of period end |
| 2014-12-31 | $531.0K | n/m | 2016-03-25, Balance as of period end |
| 2013-12-31 | $39.0K | -39.5% | 2015-03-11, Balance as of period end |
| 2012-12-31 | $64.4K | n/m | 2014-03-19, Balance as of period end |
| 2011-12-31 | $3.4K | -69.9% | 2013-03-15, Balance as of period end |
| 2010-12-31 | $11.4K | n/a | 2012-03-19, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $7.04M | -0.3% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $6.64M | -34.4% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $1.93M | -40.0% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $22.39M | -65.0% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $41.92M | +370.4% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $11.64M | -0.5% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $18.08M | +2.4% |
| Verastem, Inc. (VSTM) | 2025-12-31 | $189.25M | +45.1% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $306.60M | -7.0% |
Compare SBFM, LIFD, ETST, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗